exhausted on semaglutide Feeling semaglutide? You're not imagining it — and you're not alone. Fatigue is one of the most common early side effects reported with GLP-1 medications. Your body is adapting to Why Semaglutide Makes You Tired:

Uncover Seattle's innovative role in weight loss via Ozempic

90-Day Real Results Promise

In spring 2025, the Food and Drug Administration (FDA) resolved and ended the GLP-1 medications shortage, subsequently releasing declaratory orders that neither outsourcing compounding pharmacies or pharmacies could compound drugs that were essentially copies of either semaglutide (available under the brand names Ozempic, Rybelsus, and Wegovy) and tirzepatide (available under the brand names Mounjaro, and Zepbound).

The consistent, substantial kidney and cardiovascular benefits of these agents has led to their incorporation into professional guidelines as foundational care for type 2 diabetes

Breaking data at ADA 2024: results from the first dedicated kidney outcomes trial with a GLP-1RA.